The Remember Me feature is an automatic login process which creates a cookie on the hard drive of your computer containing a unique identifier which ASCO.org will utilize to remember you by, thereby avoiding the need to enter username and password upon subsequent visits to ASCO.org. DO NOT select this option if you share this computer with others since transactional, personal, or member only information will be accessible by other users.

To activate the Remember Me option, click the empty check box when signing in to the site. The Remember Me functionality is deactivated at the logout.

For additional information please review our Privacy Policy.


Redefining the Role of Taxanes in Cancer Therapy: Using Technology To Take Taxanes Where No Taxanes Have Gone Before


This presentation was selected by the American Society of Clinical Oncology® as an independent educational activity held in conjunction with an ASCO meeting. This presentation is not sponsored or endorsed by ASCO.

Redefining the Role of Taxanes in Cancer Therapy: Using Technology To Take Taxanes Where No Taxanes Have Gone Before


Welcome and Introductions
Speaker: Alexander M Eggermont

Historical Perspective on Taxanes in Cancer Therapy
Speaker: Stephen E. Jones

Targeted Taxanes: Enhancing the Utility of Taxanes in Challenging Tumor Types
Speaker: Andrew D Seidman

Novel Taxane Formulations in Breast Cancer: Where Do We Stand, and What Does the Future Hold?
Speaker: Kimberly L. Blackwell

Decision Making in Advanced Breast Cancer: Case-Based Discussion
Speaker: Andrew D Seidman

Taxanes in Melanoma: Can SPARC Mediate Effectiveness?
Speaker: Alexander M Eggermont

Clinical Data on Novel Taxanes in Pancreatic Cancer
Speaker: Caio Max S. Rocha Lima

Improving the Therapeutic Ratio of Chemotherapy in Metastatic Non-Small-Cell Lung Cancer
Speaker: Vincent A Miller

Postsession Survey and Questions and Answer Session
Speaker: Alexander M Eggermont





 
2318 Mill Road, Suite 800, Alexandria, VA 22314   |   phone: (571) 483-1300
© 2005-2009 American Society of Clinical Oncology (ASCO).  All rights reserved worldwide.